The Public Cannabis Company Revenue Tracker, managed by New Cannabis Ventures, ranks the top revenue producing cannabis stocks that generate industry sales of more than $2.5m per quarter. This data-driven, fact-based tracker will continually update based on new filings so that readers can stay up to date. Companies must file with the SEC or SEDAR to be considered for inclusion.
Sixteen companies currently qualify for inclusion, with seven filing in U.S dollars and nine in the Canadian currency. We have updated the Canadian list to add Isodiol International (CSE: ISOL) (OTC: ISOLF), which markets CBD derived from industrial hemp and reported sales in its FY18-Q2 of C$5.06mm. Additionally, MPX Bioceutical (CSE: MPX) (OTC: MPXEF) reported sales of C$4.41mm in its FY18-Q2, with all of its revenue generated in its Arizona operations. Canadian licensed producer CannTrust (CSE: TRST) (OTC: CNTTF) reported sales for Q3 of $C$6.14mm, representing 680% growth from the same quarter in 2016.
In the United States, Kush Bottles (OTC: KSHB) reported sales for its FY17-Q4 ending 8/31 of $8.64mm, representing growth of 264% from a year ago. Excluding the contribution of sales from recently acquired CMP Wellness, sales grew 84%. We also added Golden Leaf Holdings (CSE: GLH) (OTC: GLDFF), which reported sales of $3.13mm, a gain of 29% from a year ago that was boosted by its recent acquisition of Chalice Farms.
Visit the Public Cannabis Company Revenue Tracker to see the complete list of qualifying companies.
Before this cannabis stock news is here, it's published to subscribers on 420 Investor.
Based in Houston, Alan leverages his experience as founder of online communities 420 Investor, the first and still largest due diligence platform focused on the publicly-traded stocks in the cannabis industry. With his extensive network in the cannabis community, Alan continues to find new ways to connect the industry and facilitate its sustainable growth. At New Cannabis Ventures, he is responsible for content development and strategic alliances. Before shifting his focus to the cannabis industry in early 2013, Alan, who began his career on Wall Street in 1986, worked as an independent research analyst following over two decades in research and portfolio management. A prolific writer, with over 650 articles published since 2007 at Seeking Alpha, where he has 70,000 followers, Alan is a frequent speaker at industry conferences and a frequent source to the media, including the NY Times, the Wall Street Journal, Fox Business, and Bloomberg TV.
Contact Alan: Twitter | Facebook | LinkedIn | Email